{
  "actions": [
    {
      "acted_at": "2001-06-14", 
      "references": [
        {
          "reference": "CR S6329", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-06-14", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1049-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "107", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-06-14", 
  "number": "1049", 
  "official_title": "A bill to provide for an election to exchange research-related tax benefits for a refundable tax credit, for the recapture of refunds in certain circumstances, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "American Breakthrough Research Act of 2001", 
  "sponsor": {
    "district": null, 
    "name": "Torricelli, Robert G.", 
    "state": "NJ", 
    "thomas_id": "01163", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-06-14", 
  "subjects": [
    "Business income tax", 
    "Business losses", 
    "Clinical trials", 
    "Commerce", 
    "Corporation taxes", 
    "Health", 
    "Income tax", 
    "Orphan drugs", 
    "Pharmaceutical research", 
    "Research and development tax credit", 
    "Science, technology, communications", 
    "Tax deductions", 
    "Tax penalties", 
    "Tax refunds", 
    "Taxation"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-06-14", 
    "text": "American Breakthrough Research Act of 2001 - Amends the Internal Revenue Code to allow a qualified research corporation to elect a refundable credit in the amount of the sum of the discounted research credits and discounted research net operating loss (NOL) in lieu of taking its research credits and research NOLs. (Defines terms for purposes of such credit.)Prohibits an electing corporation from using nonrelinquished research or NOL tax credits until such corporation has paid back the original amount of the refundable credit in Federal income taxes.Provides for credit recapture in the event of failure to increase research activity."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "American Breakthrough Research Act of 2001", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to provide for an election to exchange research-related tax benefits for a refundable tax credit, for the recapture of refunds in certain circumstances, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:47:00-05:00"
}